Formyl peptide receptor-1 activation enhances intestinal epithelial cell restitution through phosphatidylinositol 3-kinase-dependent activation of Rac1 and Cdc42

Journal of Immunology

Volumn 179, Issue 12, 2007, Pages 8112-8121

  Babbin, Brian A ^a   Jesaitis, Algirdas J ^b   Ivanov, Andrei I ^a   Kelly, Daina ^a   Laukoetter, Mike ^a   Nava, Porfirio ^a   Parkos, Charles A ^a   Nusrat, Asma ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MONTANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FORMYLPEPTIDE RECEPTOR LIKE 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN CDC42; RAC1 PROTEIN; FORMYLPEPTIDE RECEPTOR; FPR1 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ARTICLE; CELL ACTIVATION; CELL CULTURE; CELL DIFFERENTIATION; CELL FUNCTION; CELL LINE; CELL MIGRATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LOCALIZATION; EPITHELIUM CELL; GASTROINTESTINAL TRACT; HUMAN; HUMAN CELL; IMMUNOLOCALIZATION; INFLAMMATORY DISEASE; INNATE IMMUNITY; INTESTINE EPITHELIUM; INTESTINE FUNCTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WOUND CLOSURE; WOUND HEALING; CELL MOTION; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; ENZYMOLOGY; INJURY; INTESTINE MUCOSA; METABOLISM; PHYSIOLOGY;

1-PHOSPHATIDYLINOSITOL 3-KINASE; CDC42 GTP-BINDING PROTEIN; CELL LINE; CELL MOVEMENT; HUMANS; INTESTINAL MUCOSA; RAC1 GTP-BINDING PROTEIN; RECEPTORS, FORMYL PEPTIDE; WOUND HEALING;

EID: 40049099793     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.12.8112     Document Type: Article

References (81)

1. Lauffenburger, D. A., and A. F. Horwitz. 1996. Cell migration: a physically integrated molecular process. Cell 84: 359-369.
2. Fenteany, G., P. A. Janmey, and T. P. Stossel. 2000. Signaling pathways and cell mechanics involved in wound closure by epithelial cell sheets. Curr. Biol. 10: 831-838.
3. Li, S., J. L. Guan, and S. Chien. 2005. Biochemistry and biomechanics of cell motility. Annu. Rev. Biomed. Eng. 7: 105-150.
4. Royal, I., N. Lamarche-Vane, L. Lamorte, K. Kaibuchi, and M. Park. 2000. Activation of Cdc42, Rac, PAK, and Rho-kinase in response to hepatocyte growth factor differentially regulates epithelial cell colony spreading and dissociation. Mol. Biol. Cell 11: 1709-1725.
5. Paruchuri, S., O. Broom, K. Dib, and A. Sjolander. 2005. The pro-inflammatory mediator leukotriene D4 induces phosphatidylinositol 3-kinase and Rac-dependent migration of intestinal epithelial cells. J. Biol. Chem. 280: 13538-13544.
6. Hopkins, A. M., M. Bruewer, G. T. Brown, A. A. Pineda, J. J. Ha, L. M. Winfree, S. V. Walsh, B. A. Babbin, and A. Nusrat. 2004. Epithelial cell spreading induced by hepatocyte growth factor influences paxillin protein synthesis and posttranslational modification. Am. J. Physiol. 287: G886-G898.
7. Van Leeuwen, F. N., B. N. Giepmans, L. A. van Meeteren, and W. H. Moolenaar. 2003. Lysophosphatidic acid: mitogen and motility factor. Biochem. Soc. Trans. 31: 1209-1212.
8. Moolenaar, W. H. 1994. LPA: a novel lipid mediator with diverse biological actions. Trends Cell Biol. 4: 213-219.
9. Rameh, L. E., and L. C. Cantley. 1999. The role of phosphoinositide 3-kinase lipid products in cell function. J. Biol. Chem. 274: 8347-8350.
10. Cantley, L. C. 2002. The phosphoinositide 3-kinase pathway. Science 296: 1655-1657.
11. Wymann, M. P., and L. Pirola. 1998. Structure and function of phosphoinositide 3-kinases. Biochim. Biophys. Acta. 1436: 127-150.
12. Welch, H. C., W. J. Coadwell, L. R. Stephens, and P. T. Hawkins. 2003. Phosphoinositide 3-kinase-dependent activation of Rac. FEBS Lett. 546: 93-97.
13. Rabiet, M. J., E. Huet, and F. Boulay. 2007. The N-formyl peptide receptors and the anaphylatoxin C5a receptors: an overview. Biochimie 89: 1089-1106.
14. Katanaev, V. L. 2001. Signal transduction in neutrophil chemotaxis. Biochemistry 66: 351-368.
15. Nobes, C. D., and A. Hall. 1995. Rho, Rac and Cdc42 GTPases: regulators of actin structures, cell adhesion and motility. Biochem. Soc. Trans. 23: 456-459.
16. Ridley, A. J., and A. Hall. 1992. The small GTP-binding protein Rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 70: 389-399.
17. Ridley, A. J., M. A. Schwartz, K. Burridge, R. A. Firtel, M. H. Ginsberg, G. Borisy, J. T. Parsons, and A. R. Horwitz. 2003. Cell migration: integrating signals from front to back. Science 302: 1704-1709.
18. Evers, E. E., G. C. Zondag, A. Malliri, L. S. Price, J. P. ten Klooster, R. A. van der Kammen, and J. G. Collard. 2000. Rho family proteins in cell adhesion and cell migration. Eur. J. Cancer 36: 1269-1274.
19. Schmidt, A., and A. Hall. 2002. Guanine nucleotide exchange factors for Rho GTPases: turning on the switch. Genes Dev. 16: 1587-1609.
20. Le, Y., P. M. Murphy, and J. M. Wang. 2002. Formyl-peptide receptors revisited. Trends Immunol. 23: 541-548.
21. Selvatici, R., S. Falzarano, A. Mollica, and S. Spisani. 2006. Signal transduction pathways triggered by selective formylpeptide analogues in human neutrophils. Eur. J. Pharmacol. 534: 1-11.
22. Selvatici, R., S. Falzarano, S. Traniello, G. Pagani Zecchini, and S. Spisani. 2003. Formylpeptides trigger selective molecular pathways that are required in the physiological functions of human neutrophils. Cell. Signal. 15: 377-383.
23. Quinn, M. T., T. Evans, L. R. Loetterle, A. J. Jesaitis, and G. M. Bokoch. 1993. Translocation of Rac correlates with NADPH oxidase activation: evidence for equimolar translocation of oxidase components. J. Biol. Chem. 268: 20983-20987.
24. Nore, B. F., L. Vargas, A. J. Mohamed, L. J. Branden, C. M. Backesjo, T. C. Islam, P. T. Mattsson, K. Hultenby, B. Christensson, and C. I. Smith. 2000. Redistribution of Bruton's tyrosine kinase by activation of phosphatidylinositol 3-kinase and Rho-family GTPases. Eur. J. Immunol. 30: 145-154.
25. Hirsch, E., V. L. Katanaev, C. Garlanda, O. Azzolino, L. Pirola, L. Silengo, S. Sozzani, A. Mantovani, F. Altruda, and M. P. Wymann. 2000. Central role for G protein-coupled phosphoinositide 3-kinase γ in inflammation. Science 287: 1049-1053.
26. Hannigan, M. O., C. K. Huang, and D. Q. Wu. 2004. Roles of PI3K in neutrophil function. Curr. Top. Microbiol. Immunol. 282: 165-175.
27. Hannigan, M., L. Zhan, Z. Li, Y. Ai, D. Wu, and C. K. Huang. 2002. Neutrophils lacking phosphoinositide 3-kinase γ show loss of directionality during N-formyl-Met-Leu-Phe-induced chemotaxis. Proc. Natl. Acad. Sci. USA 99: 3603-3608.
28. Worthylake, R. A., and K. Burridge. 2001. Leukocyte transendothelial migration: orchestrating the underlying molecular machinery. Curr. Opin. Cell Biol. 13: 569-577.
29. Merlot, S., and R. A. Firtel. 2003. Leading the way: directional sensing through phosphatidylinositol 3-kinase and other signaling pathways. J. Cell Sci. 116: 3471-3478.
30. Hsu, M. H., S. C. Chiang, R. D. Ye, and E. R. Prossnitz. 1997. Phosphorylation of the N-formyl peptide receptor is required for receptor internalization but not chemotaxis. J. Biol. Chem. 272: 29426-29429.
31. Diviani, D., A. L. Lattion, and S. Cotecchia. 1997. Characterization of the phosphorylation sites involved in G protein-coupled receptor kinase- and protein kinase C-mediated desensitization of the α1B-adrenergic receptor. J. Biol. Chem. 272: 28712-28719.
32. Potter, R. M., D. C. Maestas, D. F. Cimino, and E. R. Prossnitz. 2006. Regulation of N-formyl peptide receptor signaling and trafficking by individual carboxyl-terminal serine and threonine residues. J. Immunol. 176: 5418-5425.
33. Becker, E. L., F. A. Forouhar, M. L. Grunnet, F. Boulay, M. Tardif, B. J. Bormann, D. Sodja, R. D. Ye, J. R. Woska, Jr., and P. M. Murphy. 1998. Broad immunocytochemical localization of the formylpeptide receptor in human organs, tissues, and cells. Cell Tissue Res. 292: 129-135.
34. VanCompernolle, S. E., K. L. Clark, K. A. Rummel, and S. C. Todd. 2003. Expression and function of formyl peptide receptors on human fibroblast cells. J. Immunol. 171: 2050-2056.
35. Rescher, U., A. Danielczyk, A. Markoff, and V. Gerke. 2002. Functional activation of the formyl peptide receptor by a new endogenous ligand in human lung A549 cells. J. Immunol. 169: 1500-1504.
36. McCoy, R., D. L. Haviland, E. P. Molmenti, T. Ziambaras, R. A. Wetsel, and D. H. Perlmutter. 1995. N-formylpeptide and complement C5a receptors are expressed in liver cells and mediate hepatic acute phase gene regulation. J. Exp. Med. 182: 207-217.
37. Babbin, B. A., W. Y. Lee, C. A. Parkos, L. M. Winfree, A. Akyildiz, M. Perretti, and A. Nusrat. 2006. Annexin I regulates SKCO-15 cell invasion by signaling through formyl peptide receptors. J. Biol. Chem. 281: 19588-19599.
38. Lisanti, M. P., I. W. Caras, M. A. Davitz, and E. Rodriguez-Boulan. 1989. A glycophospholipid membrane anchor acts as an apical targeting signal in polarized epithelial cells. J. Cell Biol. 109: 2145-2156.
39. Mandell, K. J., B. A. Babbin, A. Nusrat, and C. A. Parkos. 2005. Junctional adhesion molecule-1 (JAM1) regulates epithelial cell morphology through effects on β 1 integrins and Rap1 activity. J. Biol. Chem. 280: 11665-11674.
40. Wang, J. Y., J. Li, A. R. Patel, S. Summers, L. Li, and B. L. Bass. 1998. Synergistic induction of ornithine decarboxylase by asparagine and gut peptides in intestinal crypt cells. Am. J. Physiol. 274: C1476-C1484.
41. Riesselman, M., H. M. Miettinen, J. M. Gripentrog, C. I. Lord, B. Mumey, E. A. Dratz, J. Stie, R. M. Taylor, and A. J. Jesaitis. 2007. C-terminal tail phosphorylation of N-formyl peptide receptor: differential recognition of two neutrophil chemoattractant receptors by monoclonal antibodies NFPR1 and NFPR2. J. Immunol. 179: 2520-2531.
42. Gao, Y., J. B. Dickerson, F. Guo, J. Zheng, and Y. Zheng. 2004. Rational design and characterization of a Rac GTPase-specific small molecule inhibitor. Proc. Natl. Acad. Sci. USA 101: 7618-7623.
43. Pelish, H. E., J. R. Peterson, S. B. Salvarezza, E. Rodriguez-Boulan, J. L. Chen, M. Stamnes, E. Macia, Y. Feng, M. D. Shair, and T. Kirchhausen. 2006. Secramine inhibits Cdc42-dependent functions in cells and Cdc42 activation in vitro. Nat. Chem. Biol. 2: 39-46.
44. Xu, B., H. Pelish, T. Kirchhausen, and G. B. Hammond. 2006. Large scale synthesis of the Cdc42 inhibitor secramine A and its inhibition of cell spreading. Org. Biomol. Chem. 4: 4149-4157.
45. Aullo, P., M. Giry, S. Olsnes, M. R. Popoff, C. Kocks, and P. Boquet. 1993. A chimeric toxin to study the role of the 21 kDa GTP binding protein Rho in the control of actin microfilament assembly. EMBO J. 12: 921-931.
46. Tamburini, J., C. Elie, V. Bardet, N. Chapuis, S. Park, P. Broet, P. Cornillet-Lefebvre, B. Lioure, V. Ugo, O. Blanchet, et al. 2007. Constitutive phosphoinositide-3kinase/AKT activation represents a favorable prognostic factor in de novo AML patients. Blood 110: 1025-1028.
47. Hale, B. G., and R. E. Randall. 2007. PI3K signalling during influenza A virus infections. Biochem. Soc. Trans. 35: 186-187.
48. Prossnitz, E. R., and R. D. Ye. 1997. The N-formyl peptide receptor: a model for the study of chemoattractant receptor structure and function. Pharmacol. Ther. 74: 73-102.
49. Le, Y., J. J. Oppenheim, and J. M. Wang. 2001. Pleiotropic roles of formyl peptide receptors. Cytokine Growth Factor Rev. 12: 91-105.
50. Charrier, L., A. Driss, Y. Yan, V. Nduati, J. M. Klapproth, S. V. Sitaraman, and D. Merlin. 2006. hPepT1 mediates bacterial tripeptide fMLP uptake in human monocytes. Lab. Invest. 86: 490-503.
51. Merlin, D., A. Steel, A. T. Gewirtz, M. Si-Tahar, M. A. Hediger, and J. L. Madara. 1998. hPepT1-mediated epithelial transport of bacteria-derived chemotactic peptides enhances neutrophil-epithelial interactions. J. Clin. Invest. 102: 2011-2018.
52. Maffucci, T., F. T. Cooke, F. M. Foster, C. J. Traer, M. J. Fry, and M. Falasca. 2005. Class II phosphoinositide 3-kinase defines a novel signaling pathway in cell migration. J. Cell Biol. 169: 789-799.
53. Carnero, A., and J. C. Lacal. 1998. Wortmannin, an inhibitor of phosphatidylinositol 3-kinase, induces oocyte maturation through a MPF-MAPK-dependent pathway. FEBS Lett. 422: 155-159.
54. Beckwith, M., R. G. Fenton, I. M. Katona, and D. L. Longo. 1996. Phosphatidylinositol-3-kinase activity is required for the anti-Ig-mediated growth inhibition of a human B-lymphoma cell line. Blood 87: 202-210.
55. Vlahos, C. J., W. F. Matter, K. Y. Hui, and R. F. Brown. 1994. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1- benzopyran-4-one (LY294002). J. Biol. Chem. 269: 5241-5248.
56. Smith, M. V., M. J. Lee, A. S. Islam, J. L. Rohrer, V. M. Goldberg, M. A. Beidelschies, and E. M. Greenfield. 2007. Inhibition of the PI3K-Akt signaling pathway reduces tumor necrosis factor-α production in response to titanium particles in vitro. J. Bone Jt. Surg. Am. Vol. 89: 1019-1027.
57. Nobes, C. D., and A. Hall. 1999. Rho GTPases control polarity, protrusion, and adhesion during cell movement. J. Cell Biol. 144: 1235-1244.
58. Gharbi, S. I., M. J. Zvelebil, S. J. Shuttleworth, T. Hancox, N. Saghir, J. F. Timms, and M. D. Waterfield. 2007. Exploring the specificity of the PI3K family inhibitor LY294002. Biochem. J. 404: 15-21.
59. Rabiet, M. J., E. Huet, and F. Boulay. 2005. Human mitochondria-derived N-formylated peptides are novel agonists equally active on FPR and FPRL1, while Listeria monocytogenes-derived peptides preferentially activate FPR. Eur. J. Immunol. 35: 2486-2495.
60. Carp, H. 1982. Mitochondrial N-formylmethionyl proteins as chemoattractants for neutrophils. J. Exp. Med. 155: 264-275.
61. Marasco, W. A., S. H. Phan, H. Krutzsch, H. J. Showell, D. E. Feltner, R. Nairn, E. L. Becker, and P. A. Ward. 1984. Purification and identification of formyl-methionyl-leucyl-phenylalanine as the major peptide neutrophil chemotactic factor produced by Escherichia coli. J. Biol. Chem. 259: 5430-5439.
62. Gao, J. L., E. J. Lee, and P. M. Murphy. 1999. Impaired antibacterial host defense in mice lacking the N-formylpeptide receptor. J. Exp. Med. 189: 657-662.
63. Gunzel, D., P. Florian, J. F. Richter, H. Troeger, J. D. Schulzke, M. Fromm, and A. H. Gitter. 2006. Restitution of single-cell defects in the mouse colon epithelium differs from that of cultured cells. Am. J. Physiol. 290: R1496-R1507.
64. Henson, J. H., R. Nazarian, K. L. Schulberg, V. A. Trabosh, S. E. Kolnik, A. R. Burns, and K. J. McPartland. 2002. Wound closure in the lamellipodia of single cells: mediation by actin polymerization in the absence of an actomyosin purse string. Mol. Biol. Cell 13: 1001-1014.
65. Jesaitis, A. J., R. W. Erickson, K. N. Klotz, R. K. Bommakanti, and D. W. Siemsen. 1993. Functional molecular complexes of human N-formyl chemoattractant receptors and actin. J. Immunol. 151: 5653-5665.
66. Jesaitis, A. J., J. O. Tolley, and R. A. Allen. 1986. Receptor-cytoskeleton interactions and membrane traffic may regulate chemoattractant-induced superoxide production in human granulocytes. J. Biol. Chem. 261: 13662-13669.
67. Jesaitis, A. J., J. O. Tolley, R. G. Painter, L. A. Sklar, and C. G. Cochrane. 1985. Membrane-cytoskeleton interactions and the regulation of chemotactic peptide-induced activation of human granulocytes: the effects of dihydrocytochalasin B. J. Cell. Biochem. 27: 241-253.
68. Jesaitis, A. J., J. R. Naemura, L. A. Sklar, C. G. Cochrane, and R. G. Painter. 1984. Rapid modulation of N-formyl chemotactic peptide receptors on the surface of human granulocytes: formation of high-affinity ligand-receptor complexes in transient association with cytoskeleton. J. Cell Biol. 98: 1378-1387.
69. Jesaitis, A. J., J. R. Naemura, R. G. Painter, L. A. Sklar, and C. G. Cochrane. 1983. The fate of an N-formylated chemotactic peptide in stimulated human granulocytes: subcellular fractionation studies. J. Biol. Chem. 258: 1968-1977.
70. Klotz, K. N., K. L. Krotec, J. Gripentrog, and A. J. Jesaitis. 1994. Regulatory interaction of N-formyl peptide chemoattractant receptors with the membrane skeleton in human neutrophils. J. Immunol. 152: 801-810.
71. Ido, A., M. Numata, M. Kodama, and H. Tsubouchi. 2005. Mucosal repair and growth factors: recombinant human hepatocyte growth factor as an innovative therapy for inflammatory bowel disease. J. Gastroenterol. 40: 925-931.
72. Polk, D. B. 1998. Epidermal growth factor receptor-stimulated intestinal epithelial cell migration requires phospholipase C activity. Gastroenterology 114: 493-502.
73. El-Assal, O. N., and G. E. Besner. 2005. HB-EGF enhances restitution after intestinal ischemia/reperfusion via PI3K/Akt and MEK/ERK1/2 activation. Gastroenterology 129: 609-625.
74. Moolenaar, W. H., O. Kranenburg, F. R. Postma, and G. C. Zondag. 1997. Lysophosphatidic acid: G-protein signalling and cellular responses. Curr. Opin. Cell Biol. 9: 168-173.
75. Santos, M. F., S. A. McCormack, Z. Guo, J. Okolicany, Y. Zheng, L. R. Johnson, and G. Tigyi. 1997. Rho proteins play a critical role in cell migration during the early phase of mucosal restitution. J. Clin. Invest. 100: 216-225.
76. Cerione, R. A., and Y. Zheng. 1996. The Dbl family of oncogenes. Curr. Opin. Cell Biol. 8: 216-222.
77. Srinivasan, S., F. Wang, S. Glavas, A. Ott, F. Hofmann, K. Aktories, D. Kalman, and H. R. Bourne. 2003. Rac and Cdc42 play distinct roles in regulating PI(3,4,5)P3 and polarity during neutrophil chemotaxis. J. Cell Biol. 160: 375-385.
78. Cory, G. O., and A. J. Ridley. 2002. Cell motility: braking WAVEs. Nature 418: 732-733.
79. Itoh, R. E., K. Kurokawa, Y. Ohba, H. Yoshizaki, N. Mochizuki, and M. Matsuda. 2002. Activation of Rac and Cdc42 video imaged by fluorescent resonance energy transfer-based single-molecule probes in the membrane of living cells. Mol. Cell. Biol. 22: 6582-6591.
80. Etienne-Manneville, S., and A. Hall. 2001. Integrin-mediated activation of Cdc42 controls cell polarity in migrating astrocytes through PKCζ. Cell 106: 489-498.
81. Etienne-Manneville, S., and A. Hall. 2002. Rho GTPases in cell biology. Nature 420: 629-635.